Drug Patent Expirations for the Week of March 10, 2019

SYNRIBO (omacetaxine mepesuccinate) Teva pharms intl Patent: RE45128 Expiration: Mar 16, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expiration…


Meet in Philadephia/NJ

I will be in Philadelphia on April 11th and 12th and would enjoy the opportunity to meet with current and prospective clients to learn more about your needs. If you…
The post Meet in Philadephia/NJ appeared first on DrugPatentWatch – Make Better Decisi…


Drug Patent Expirations for the Week of March 10, 2019

SYNRIBO (omacetaxine mepesuccinate) Teva pharms intl Patent: RE45128 Expiration: Mar 16, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expiration…


Generic companies with the most tentative approvals

This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2018 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic…
The post Generic companies with the most tent…


Do NOT follow this link or you will be banned from the site!